Impact of Oncotype DX on treatment decisions in ER-positive, node-negative breast cancer with histologic correlation.
about
How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experimentThe clinical impact of 21-gene recurrence score on treatment decisions for patients with hormone receptor-positive early breast cancer in Korea.Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer.Implementation of the 21-gene recurrence score test in the United States in 2011.GENE EXPRESSION PROFILING AND EXPANDED IMMUNOHISTOCHEMISTRY TESTS TO GUIDE SELECTION OF CHEMOTHERAPY REGIMENS IN BREAST CANCER MANAGEMENT: A SYSTEMATIC REVIEW.Using the Modified Magee Equation to Identify Patients Unlikely to Benefit From the 21-Gene Recurrence Score Assay (Oncotype DX Assay).21-Gene recurrence score testing among Medicare beneficiaries with breast cancer in 2010-2013.Apparent diffusion coefficient in estrogen receptor-positive and lymph node-negative invasive breast cancers at 3.0T DW-MRI: A potential predictor for an oncotype Dx test recurrence score.Use of modified Magee equations and histologic criteria to predict the Oncotype DX recurrence score.
P2860
Q24658523-D5EC1EFA-A855-4542-8516-42972FAF3FAEQ35430076-C63D3471-AEE8-4C89-92D2-2117B28342C8Q36914381-57A7D331-7EC3-4F28-9A7C-28EDD76E16D5Q38409617-B0B0A303-A441-407E-9C44-21ECC409F81FQ38795484-6F32E90B-9AF5-4445-99F2-F1EFC5DC5352Q47869675-08FEEEE9-BAF2-436E-9F38-968E2DF3951DQ47918429-AC8CC529-890F-4717-BB26-C13FE0B970B4Q48236804-470F5F13-8B60-45A8-9DC7-D1CC7981F07FQ50921836-89621D74-17C9-45D7-B26B-0C9564E850E1
P2860
Impact of Oncotype DX on treatment decisions in ER-positive, node-negative breast cancer with histologic correlation.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Impact of Oncotype DX on treat ...... r with histologic correlation.
@ast
Impact of Oncotype DX on treat ...... r with histologic correlation.
@en
Impact of Oncotype DX on treat ...... r with histologic correlation.
@nl
type
label
Impact of Oncotype DX on treat ...... r with histologic correlation.
@ast
Impact of Oncotype DX on treat ...... r with histologic correlation.
@en
Impact of Oncotype DX on treat ...... r with histologic correlation.
@nl
prefLabel
Impact of Oncotype DX on treat ...... r with histologic correlation.
@ast
Impact of Oncotype DX on treat ...... r with histologic correlation.
@en
Impact of Oncotype DX on treat ...... r with histologic correlation.
@nl
P2093
P2860
P356
P1433
P1476
Impact of Oncotype DX on treat ...... r with histologic correlation.
@en
P2093
Adam D Toll
Gordon F Schwartz
Juan P Palazzo
Julianne R Biroschak
Kristin L Brill
Rebecca J Jaslow
Sun Yong Lee
P2860
P304
P356
10.1111/TBJ.12099
P577
2013-05-01T00:00:00Z